Safety and Efficacy of NK510 to Treat Gastric Cancer
Clinical trial NCT06098898 · UNKNOWN
Trial details
- NCT number
- NCT06098898
- Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-11-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.